+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Polycythemia Vera Drugs - Global Strategic Business Report - Product Thumbnail Image

Polycythemia Vera Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 272 Pages
  • Global
From
Prion Disease Treatment - Global Strategic Business Report - Product Thumbnail Image

Prion Disease Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 268 Pages
  • Global
From
Rosai-Dorfman Disease - Global Strategic Business Report - Product Thumbnail Image

Rosai-Dorfman Disease - Global Strategic Business Report

  • Report
  • September 2025
  • 372 Pages
  • Global
From
Rivaroxaban - Global Strategic Business Report - Product Thumbnail Image

Rivaroxaban - Global Strategic Business Report

  • Report
  • September 2025
  • 470 Pages
  • Global
From
Sciatica Treatment - Global Strategic Business Report - Product Thumbnail Image

Sciatica Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 380 Pages
  • Global
From
From
Anti-Inflammatory Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Inflammatory Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 488 Pages
  • Global
From
Appendicitis Treatment - Global Strategic Business Report - Product Thumbnail Image

Appendicitis Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 386 Pages
  • Global
From
Barth Syndrome Treatment - Global Strategic Business Report - Product Thumbnail Image

Barth Syndrome Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 486 Pages
  • Global
From
Benzodiazepine Drugs - Global Strategic Business Report - Product Thumbnail Image

Benzodiazepine Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 388 Pages
  • Global
From
Bipolar Disorder Treatment - Global Strategic Business Report - Product Thumbnail Image

Bipolar Disorder Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 387 Pages
  • Global
From
Camylofin - Global Strategic Business Report - Product Thumbnail Image

Camylofin - Global Strategic Business Report

  • Report
  • September 2025
  • 380 Pages
  • Global
From
Cardiotonic Agents - Global Strategic Business Report - Product Thumbnail Image

Cardiotonic Agents - Global Strategic Business Report

  • Report
  • September 2025
  • 568 Pages
  • Global
From
Ceftriaxone - Global Strategic Business Report - Product Thumbnail Image

Ceftriaxone - Global Strategic Business Report

  • Report
  • September 2025
  • 281 Pages
  • Global
From
From
Cold Sore Treatment - Global Strategic Business Report - Product Thumbnail Image

Cold Sore Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 469 Pages
  • Global
From
Cyproterone Acetate - Global Strategic Business Report - Product Thumbnail Image

Cyproterone Acetate - Global Strategic Business Report

  • Report
  • September 2025
  • 287 Pages
  • Global
From
Deferiprone - Global Strategic Business Report - Product Thumbnail Image

Deferiprone - Global Strategic Business Report

  • Report
  • September 2025
  • 359 Pages
  • Global
From
From
Diabetic Gastroparesis Treatment - Global Strategic Business Report - Product Thumbnail Image

Diabetic Gastroparesis Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 368 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more